Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Sochaczew

36 clinical trials in Sochaczew, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Sochaczew at a glance
36
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

36 trials in Sochaczew

Open in trial search

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Agitation+1

Recruiting

A study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dextromethorphan Hydrobromide

A study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer's disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Gouty arthritis

Recruiting

A study comparing dotinurad and allopurinol for lowering uric acid levels in adults with gout and high uric acid in the blood.

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Allopurinol
  • Sponsor:Crystalys Therapeutics Inc.

Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Psychotic disorder+1

Recruiting

Study of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer's disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Parkinson's disease

Not yet recruiting

A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ioflupane (123I)
  • Sponsor:Biohaven Therapeutics Ltd.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Sochaczew

What the registry says about research in the country

01 Inflammatory Conditions

Clinical studies focusing on psoriatic arthritis and plaque psoriasis, evaluating new therapeutic approaches and treatment effectiveness. Multiple trials are investigating innovative medications for managing these chronic inflammatory conditions.

  • Psoriatic Arthritis Treatment Studies
  • Plaque Psoriasis Management
  • Autoimmune Disease Therapies

Research includes assessment of novel biologics and comparative studies between different treatment options.

02 Respiratory Health

Innovative research on respiratory diseases including studies on influenza vaccines, RSV infections, and COPD management. These trials aim to enhance prevention and treatment strategies for respiratory conditions.

  • Vaccine Development
  • COPD Treatment
  • Respiratory Infection Prevention

Focus on both preventive measures and therapeutic interventions for respiratory illnesses.

03 Neurological Disorders

Studies addressing migraine prevention and Alzheimer's-related conditions. Research includes evaluation of new treatments for chronic pain conditions and agitation in dementia patients.

  • Migraine Prevention Therapies
  • Alzheimer's Disease Management
  • Neuropathic Pain Treatment

Comprehensive approach to addressing both symptoms and underlying conditions.

04 Cardiovascular Research

Advanced studies in cardiovascular disease and heart failure management, investigating new therapeutic approaches and combination treatments to improve patient outcomes.

  • Cardiovascular Risk Reduction
  • Heart Failure Treatment
  • Preventive Cardiology

Focus on innovative therapies and prevention strategies for heart-related conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.